Quick Snapshot: Tell Us Who You Are and What Keeps You Up at 6 AM

• Which best describes your role and the lab you run or oversee? Options: Hospital laboratory director, Reference lab operations manager, Health system lab manager, Pathology lead, Other
• Roughly how many reportable patient results does your lab generate per weekday? Options: <500, 500–2,000, 2,001–10,000, 10,001–50,000, >50,000
• What are your laboratory's primary testing areas (select all that apply)? Options: Clinical chemistry, Immunoassay, Hematology, Coagulation, Molecular/PCR, Microbiology, Point-of-care integration, Other
• How many different analyzer platforms are currently in routine use in your core lab? Options: 1, 2, 3–4, 5+
• Can you briefly describe one recent day where turnaround time felt under significant pressure?

Are You Quietly Treating Downtime as ‘Normal’?

• When a key analyzer fails during your busiest hour, do you treat that as a true emergency or an expected annoyance? Options: Emergency—immediate escalation, Annoyance we work around, Depends on the day/team, We rarely experience failures
• How often do unplanned analyzer outages occur that require manual or workaround processes? Options: Daily, Weekly, Monthly, A few times a year, Rarely/Never
• Tell us about the most recent outage: what failed, how long it lasted, and what the immediate clinical impact was.
• How does your team typically feel and behave during these outages (stress, overtime, finger-pointing, calm triage, other)? Options: High stress/overtime, Calm and procedural, Frustrated but pragmatic, Mixed responses
• How long has your lab been experiencing that typical outage pattern? Options: <6 months, 6–12 months, 1–3 years, 3+ years

What’s Getting in the Way of Smooth Mornings?

• How much of your morning surge capacity depends on manual rerouting, overtime, or temporary staffing rather than analyzer headroom? Options: Mostly manual workarounds, A balanced mix, Mostly analyzer capacity, We don’t have a predictable surge
• What manual steps or workarounds are used when throughput is exceeded (e.g., batching, offline testing, sending out, delayed reporting)? Options: Batching samples, Pulling samples to another bench, Sending out to reference lab, Delay reporting, Other
• How many extra staff-hours or overtime shifts does your team add on a typical high-volume day? Options: None, 1–4 hours, 5–12 hours, More than 12 hours
• When you make those workarounds, what downstream risks increase (clinician dissatisfaction, quality issues, overtime cost, regulatory exposure)? Options: Clinician dissatisfaction, Quality control risk, Increased cost, Regulatory/compliance risk, Other
• Is there a recurring small problem that you’ve learned to ignore that, if solved, would meaningfully reduce morning pressure? Describe it.

What Would It Feel Like If the Morning Rush Was Reliable?

• If your analyzers consistently met your morning TAT targets, how would that change clinician relationships and staff morale? Options: Greatly improve both, Improve morale more than clinician trust, Improve clinician trust more than morale, Little change
• What target turnaround times and uptime percentages would make you feel comfortable committing to critical clinical workflows? Options: TAT targets (open response), Uptime targets (open response)
• How important is reagent onboard stability (days of open vial/onboard life) to reducing morning disruptions? Options: Mission-critical, Very important, Somewhat important, Not important
• Are there test menu additions or faster assays that would directly reduce send-outs or emergency decisions? Which ones?
• If you could change one operational constraint today (space, staff, analyzer throughput, reagent supply), which would create the biggest impact? Options: More throughput, Longer reagent stability, Faster service response, Better inventory control, Other

What Assumptions Are Holding Back a Better Solution?

• Which single gate most commonly stalls new analyzer purchases in your organization—clinical validation, capital approval, procurement negotiation, or long-term service concerns? Options: Clinical validation, Capital approval, Procurement/contracts, Service/SLA concerns, Other
• Who are the decision-makers and influencers we should engage to accelerate a purchase if clinical need is proven? Options: Lab director, COO/CFO, Supply chain, Medical executive committee, Quality/regulatory, Other
• What metrics or evidence have convinced your leadership in the past (e.g., percent reduction in TAT breaches, cost-per-result analysis, uptime guarantees)? Options: TAT improvement, Cost-per-result, Uptime SLA, Reduced send-outs, Clinical impact stories, Other
• How long does your typical procurement cycle take from initial vendor engagement to purchase order? Options: <3 months, 3–6 months, 6–12 months, 12+ months
• What are the non-negotiable contractual or regulatory items that would block a deal (e.g., on-site validation scope, warranty length, response times)?

How Stable Is Your Reagent and Supply Chain, Really?

• If your primary reagent supplier had a two-week outage, how would your lab manage test continuity? Options: We have sufficient stock, Rationing/reprioritizing tests, Send outs to reference lab, We would cancel/non-urgent tests, Unsure
• How many days of critical reagent inventory do you normally carry on-site for high-volume assays? Options: <3 days, 3–7 days, 8–14 days, 15–30 days, 30+ days
• Have you experienced reagent stability issues (short shelf-life on board, frequent open-vial failures) that forced workflow changes? Options: Yes—frequently, Occasionally, Rarely, Never
• Describe one instance when reagent supply or stability impacted clinical care or your lab's operations.
• Would you be open to alternative supply models (consignment, vendor-managed inventory, guaranteed lead times) to reduce stockouts? Options: Yes—very interested, Maybe—need details, No—prefer current model

Would a Short, Focused Pilot Change the Conversation?

• Would a real-world pilot demonstrating morning throughput and uptime during your busiest week accelerate internal approval more than technical papers? Options: Yes—definitely, Possibly, Unlikely, No
• Which acceptance criteria would you require for a pilot to be persuasive (select up to three)? Options: Sustained uptime %, TAT adherence for priority tests, Throughput during surge, Reagent stability on-board days, Operator ease-of-use, Service response times
• What scope of validation would you expect during a pilot (IQ/OQ, parallel testing, comparator method agreement, sample types)? Options: IQ/OQ only, IQ/OQ + parallel clinical testing, Full method comparison, Custom limited validation, Other
• Who on your team would need to be hands-on for a pilot (names/roles) and how many hours per week could they dedicate?
• Realistically, how soon could you host a pilot if we confirmed availability and minimal disruption? Options: Immediately, Within 1 month, 1–3 months, 3–6 months, Longer

Risks, Rewards, and the Small Print That Matters

• What service response time would you require to consider a vendor reliable (on-site or remote) for high-impact outages? Options: <2 hours, 2–4 hours, 4–8 hours, Next business day
• How important is a defined warranty and uptime SLA versus ad-hoc service support when making purchase decisions? Options: SLA is critical, SLA helpful but not mandatory, Prefer flexible support, Unsure
• What financial or operational metrics should we prepare to show to your finance team (e.g., total cost-per-result, ROI timeline, avoided send-out costs)? Options: Cost-per-result, ROI timeline, Avoided send-outs, Staff time savings, Quality/regulatory risk reduction, Other
• Are there reporting or compliance formats (CAP/CLIA documentation, validation reports) that you require vendors to supply as part of implementation? Options: Full validation kit (IQ/OQ), Regulatory documentation only, Customized reporting, No standard requirement
• What would make you say 'yes' to moving forward in the next 90 days—one clear, non-technical condition?

• Current-State Confirmation Workshop (Diagnosis)
• Consequence & Impact Quantification (Cost, Time, Clinical Risk)
• Future-State Design & Throughput Proofing (Proof)
• Solution Validation Planning & Sign-off (Validation)

• Both teams to confirm the mutual decision gate criteria in writing (who signs off and what metrics must be met).
• Seller to deliver a one-page impact summary (financial + clinical) with source calculations within 3 business days.
• Customer to confirm or correct cost assumptions (labor rates, billable fees, penalty costs) within 5 business days.
• Both teams to agree on 3–5 KPIs that will be used in the future-state validation protocol.
• State the One-Sentence Future-State Outcome
• Agree on a single one-sentence future-state that addresses the prioritized consequences.
• Validate that the proposed analyzer configuration and SLA materially eliminate each specific bottleneck.
• Approve a candidate set of analyzer models and the high-level validation scenarios to prove throughput, reagent stability, and uptime.
• Confirm acceptance criteria and KPIs that will be used in the pilot/validation phase.
• Seller to provide detailed throughput calculations and a scenario simulation workbook tied to the lab's data within 3 business days.
• Customer to confirm any lab-specific constraints (e.g., shift patterns, regulatory hold-ups) that must be included in the validation scenarios.
• Seller to share SLA, maintenance plan, and reagent stability documentation linked to the proposed models.
• Both parties to finalize the list of acceptance tests and KPI thresholds for the validation protocol.
• Recap Diagnosis & Proof Outputs
• Approve a detailed validation/pilot protocol with clear pass/fail criteria tied to agreed KPIs.
• Assign owners and dates for each validation activity and commit to the decision gate for mutual next steps.
• Document major risks and agreed mitigations to avoid delays during validation.
• Obtain explicit stakeholder sign-off that the proposed future-state, if validated, will satisfy procurement and clinical requirements.
• Seller to schedule the on-site pilot window and reserve instruments, technicians, and reagents.
• Customer QA to finalize and sign the validation protocol document and return within 48 hours.
• IT and connectivity teams to confirm required interfaces and test data exchange prior to pilot start.
• Introductions & Meeting Objectives
• Produce one concise and agreed-upon current-state sentence that all stakeholders can quote.
• Identify and capture the data sources that prove the current-state (volumes, logs, TAT reports).
• Assign clear owners and deadlines for filling any data gaps before the Consequence session.
• Ensure regulatory or procurement constraints that limit solutions are documented.
• Customer to upload missing volume, failure, and reagent logs identified in the meeting within 5 business days.
• Seller to synthesize the one-sentence current-state and circulate for written sign-off within 24 hours.
• Assign a single lab point-of-contact responsible for validation data collection and Q/A follow-up.
• Recap Confirmed Current-State
• Agree on baseline KPI values (current uptime, average TAT, peak-hour backlog) that will be used to measure improvement.
• Produce quantified consequences (annualized cost, clinical-risk incidents per year) tied to the current-state.
• Align on the subset of metrics that will drive prioritization of solution options.
• Identify any additional evidence required to finalize financial assumptions.
• Read & Validate Draft Current-State Sentence
• Validation Protocol Walkthrough (IQ/OQ, Performance Tests)
• Scenario Simulation: Morning Surge & Peak Loading
• TAT and Backlog Modeling
• Financial Impact Calculation
• Define Success Metrics and Acceptance Criteria
• Data Review: Volume & Utilization
• Throughput Calculations & Bottleneck Elimination
• Data Review: Failures, Maintenance & Reagent Events
• Clinical & Compliance Risk Assessment
• Reagent Stability & Inventory Proof
• Timeline, Roles & Decision Gate
• Workflow Mapping & Affected Roles
• Risks, Mitigations & Contingencies
• Uptime, Maintenance Plan & SLA Mapping
• Prioritize Impacts and Define Which Metrics Drive Decision Urgency
• Confirm Final Current-State Sentence & Assign Data Owners
• Validation Checkpoint: 'Is this the cost/risk you experience?'
• Tie-Back Walkthrough: For Each Problem, Show How the Future-State Fixes It
• Explicit Sign-off & Next Steps
• Validation Criteria Preview

• Deliver and install analyzer system
• Connect analyzer to laboratory information system (LIS)
• Install automated sample loader and routing module
• Load, prime, and stage reagent kits for operation
• Configure onboard quality control routines and schedules
• Execute instrument calibration and performance verification
• Provide hands-on operator training and competency sessions
• Activate remote monitoring and 24/7 alerting services
• Perform preventive maintenance visit and wear-part replacement
• Respond onsite for emergency repair and module replacement
• Deploy barcode scanning and sample accessioning hardware
• Install waste handling and decontamination systems
• Enable reagent inventory management and automated reordering
• Execute IQ/OQ validation protocols and deliver documentation

Deliver and install analyzer system

• Is the delivery/install location within a hospital, reference lab, or other facility type? Options: On-site hospital lab, Reference lab facility, Off-site clinic, Other
• What is the desired delivery and installation timeframe or specific target date?
• Are there site access constraints (e.g., elevator dimensions, loading dock restrictions, stair access)? Options: Yes, No
• If site access constraints exist, provide loading dock/elevator dimensions, floor load limits, door widths, and any time windows for access.
• Will special handling, permits, or vendor credentialing be required for medical equipment delivery? Options: Yes, No
• Do you require installation to occur outside normal clinical hours (evenings/weekends) to avoid impacting operations? Options: Yes, No, Flexible
• Who will be the on-site point of contact for delivery and installation (name, role, contact)?

Connect analyzer to laboratory information system (LIS)

• Which LIS vendor and version is currently in use at the site?
• What type of interface is required to connect results and orders? Options: HL7 interface, Middleware (e.g., Data Manager), Both HL7 and middleware, None / manual
• Is there an available test environment (LIS sandbox) for integration testing? Options: Yes — test environment available, Yes — only production environment, No test environment available
• Do you require bidirectional order/resulting or unidirectional result reporting? Options: Bidirectional, Unidirectional, Not sure — need guidance
• Are there specific message formats, ACK/NAK behaviors, or custom fields required by the LIS?
• Who owns network/firewall changes and will provide IP/port whitelisting for vendor connectivity? Options: Hospital IT, Lab IT, Third-party integrator, We require vendor remote access assistance
• Provide contact details for the LIS/integration engineer and any existing interface documentation or HL7 maps.

Install automated sample loader and routing module

• Do you intend to include an automated sample loader/routing module in the initial deployment? Options: Yes, No, Partial — pilot on a single line
• What peak sample throughput (samples per hour) must the loader support, including morning surges?
• In what primary sample formats do you receive specimens? Options: Primary tubes, Microtubes, Microplates, Racks/carriers, Mixed
• Are routing rules required (e.g., STAT prioritization, batching, reflex routing to secondary modules)? Options: Yes, No
• If routing rules are required, specify the priority rules, expected logic, and example workflows.
• Do you require additional capabilities such as plate decapping/recapping, aliquoting, or barcode verification at loading? Options: Decapping/recapping, Aliquoting, Barcode verification, None
• Are there space, electrical, or power limitations at the intended installation footprint for the loader? Options: Yes, No

Load, prime, and stage reagent kits for operation

• Which assays and reagent kits should be loaded and staged at installation?
• Do any reagents require refrigerated or controlled temperature onboard storage? Options: Refrigerated onboard, Room temperature stable, Frozen storage required, Mixed requirements
• How many reagent kits (by type) do you expect to have staged at go-live?
• Do you have existing reagent lot numbers and expiration dates to verify during staging? Options: Yes, No
• Do you want vendor-managed inventory (VMI) or automated reorder configured during staging? Options: Vendor-managed inventory (VMI), Automated reorder only, No — we will manage inventory
• Who will be responsible for routine reagent replacement after handoff (vendor, lab staff, hybrid)? Options: Vendor, Lab staff, Hybrid (vendor for complex tasks)
• Do you require validation of reagent lot-to-lot performance as part of staging? Options: Yes, No

Configure onboard quality control routines and schedules

• Do you require automatic QC routines to be configured by assay (e.g., Westgard rules)? Options: Yes — vendor-standard rules, Yes — custom rules to provide, No
• What QC frequency is required (per shift, per run, per lot change, or custom)? Options: Per shift, Per run, Per lot change, Custom — specify
• Which QC materials and lot numbers should be entered into the system during configuration?
• Do you require real-time QC alarms and escalation workflows for out-of-range QC results? Options: Yes, No
• Should QC data be exported to the LIS, a separate QC management system, or both? Options: Export to LIS, Export to QC management system, Both, No export required
• Who is responsible for ongoing QC review and release of results (role/title)? Options: Lab Director, Quality Manager, Lead Technologist, Other

Execute instrument calibration and performance verification

• Which calibration standards, reference ranges, or target values should be used for each assay?
• Do you have internal SOPs for calibration and verification that must be followed? Options: Yes, No
• Is third-party verification or comparison to a reference lab required during performance verification? Options: Yes, No
• What acceptance criteria (numeric tolerances, precision thresholds) define successful verification?
• Do you require the verification documentation to be packaged specifically for CAP/CLIA inspection? Options: Yes, No
• What is the preferred timing for executing calibration and verification (immediate at install, after X days, post-training)?

Provide hands-on operator training and competency sessions

• How many operators and support staff require initial hands-on training? Options: 1-5, 6-15, 16+
• What training formats do you prefer for initial and ongoing training? Options: On-site classroom, On-site hands-on at instrument, Virtual instructor-led, Blended (mix)
• Do you require formal competency assessments and certificates for operators? Options: Yes, No
• Are there language, shift, or credential constraints that affect scheduling for training sessions?
• Do you want vendor-provided training materials, SOPs, quick-reference guides, and electronic job aids? Options: Yes, No
• Will you require periodic refresher training and, if so, preferred cadence? Options: Every 6 months, Annually, As-needed, Other

Activate remote monitoring and 24/7 alerting services

• Do you want continuous remote monitoring and telemetry enabled at go-live? Options: Yes, No, Pilot only
• Which alert channels should be used for notifications? Options: Email, SMS/text, Phone call, Vendor portal, SIEM/IT monitoring
• Do alerts require on-call escalation outside normal business hours? Options: Yes, No
• Are there network/security policies (VPN, firewall, HIPAA constraints) that restrict remote access? Options: Yes, No
• Which metrics and telemetry should be monitored (e.g., uptime, consumable levels, error codes, throughput)?
• Please provide contact roles and details for alert escalation and maintenance windows.

Perform preventive maintenance visit and wear-part replacement

• What preventive maintenance (PM) interval is preferred for your site? Options: Monthly, Quarterly, Semi-annually, Annually, Custom
• Which wear parts and consumables should be included in the standard PM kit?
• Do you prefer vendor-performed PM visits, lab-conducted PM with vendor-supplied kits, or a hybrid model? Options: Vendor-performed, Lab-performed with vendor kit, Hybrid
• Are there SLA windows required for scheduling and completing PM visits? Options: Yes — within 24-48 hours, Yes — within 7 days, No SLA required
• Do PM visits need to be scheduled during specific shifts to minimize downtime? Options: Yes, No, Flexible
• Do you require a PM report, updated logbook entries, and a parts usage summary after each visit? Options: Yes, No

Respond onsite for emergency repair and module replacement

• What is the required vendor response time for emergency onsite repairs? Options: 2 hours, 4 hours, Next business day, Other — specify
• Does your facility have local technical staff able to perform first-line troubleshooting or triage? Options: Yes, No

• Statement of Work (SOW)
• Sales Agreement / Purchase Order
• Service Level Agreement (SLA)
• Warranty & Performance Guarantee
• Reagent Supply & Inventory Agreement
• Installation & Validation Protocols (IQ/OQ/PQ)
• Training & Competency Agreement
• Capital Approval & Procurement Support Pack
• Site Acceptance Test (SAT) & Acceptance Criteria
• Maintenance & Preventive Maintenance Agreement
• Spare Parts & Consumables Agreement
• Change Order & Scope Management Process
• Data Security, Privacy & Connectivity Addendum
• Escalation Matrix & Governance Plan
• Termination, Decommissioning & Transition Plan

• Outcomes Confirmation Review
• Root Cause & Lessons Retrospective (Blameless)
• Shared Backlog Grooming & Prioritization
• Operational Handoff & SLA Confirmation
• Quarterly Business Review — Trends, Forecast & Continuous Improvement

• Agree formal acceptance or conditional acceptance language and communication plan.
• Backlog Overview & Triage Criteria
• Produce a prioritized backlog with clear owners and SLAs for critical items.
• Ensure transparent criteria so the customer understands why items are prioritized.
• Commit to a regular backlog review cadence and reporting format.
• Publish the prioritized backlog with owners, SLAs, and acceptance criteria to the shared workspace within 2 business days.
• Create engineering tickets for high-priority items and link them to backlog entries.
• Schedule recurring backlog grooming cadence (e.g., biweekly) and send calendar invites.
• Ownership & Escalation Matrix
• Lock in operational owners, PM cadence, spare parts strategy, and SLAs to sustain uptime and TAT.
• Obtain training sign-offs for operator competency and schedule ongoing training.
• Opening & Purpose
• Finalize and circulate signed SLA and escalation matrix documents.
• Create spare parts/reagent reorder triggers and confirm initial kit contents and responsible party.
• Schedule operator refresher training and confirm competency assessment dates.
• Quarterly Metrics & Trend Review
• Maintain executive alignment on performance trends and the plan to sustain or improve outcomes.
• Ensure backlog progress is transparent and that roadmap items are linked to operational impact.
• Set clear, measurable targets for the next quarter with owners and review cadence.
• Circulate the quarterly performance deck with trend charts and backlog status to all stakeholders.
• Confirm roadmap delivery dates for any high-impact product or supply improvements affecting uptime/TAT.
• Publish next quarter targets into the shared success dashboard and schedule the next QBR.
• Achieve explicit customer validation that metrics evidence either meets or does not meet the agreed success criteria.
• If unmet, agree the scope and owner of a remediation plan with timelines.
• Create a clear record of acceptance status to feed the shared backlog and contract/closing artifacts.
• Publish a timestamped outcomes report (metrics, charts, raw data) within 3 business days.
• If targets unmet, produce a remediation plan with owners and milestones within 5 business days.
• Update the shared success dashboard and mark acceptance status.
• Incident Timeline & Facts
• Identify root causes for each high-impact incident and remove ambiguity about what failed and why.
• Assign concrete corrective actions with owners and acceptance criteria.
• Ensure lessons and documentation updates are assigned and scheduled into the backlog.
• Produce RCA write-ups for each incident and share with stakeholders within 4 business days.
• Create or update SOPs and runbooks as identified and schedule training refresh sessions.
• Log corrective actions into the shared backlog with owners, due dates, and acceptance criteria.
• Backlog & Remediation Status
• Preventive Maintenance & Inventory Plan
• One-sentence Current State Recap
• Impact Quantification
• Review Top Priority Items
• Consequence Summary
• Clinician & Operational Feedback
• Prioritization Exercise
• Service SLAs, Response & Resolution Targets
• Root Cause Analysis
• Evidence Presentation: Metrics Dashboard
• Corrective & Preventive Actions
• Roadmap & Improvement Commitments
• Operator Competency & Training Sign-off
• Assignment of Owners, SLAs, and Milestones
• Next Quarter Targets & Success Criteria
• Diagnosis -> Proof -> Validation
• Cadence & Communication Plan
• Capture Lessons & Documentation Tasks
• Formal Acceptance & Communication Plan
• Decision: Accept, Conditional Accept, or Remediate